Related Experiment Videos
Single-dose trospectomycin for chlamydial urethritis in men
M C Keefer1, M A Menegus, M A Nasello
1Department of Medicine, University of Rochester School of Medicine and Dentistry, New York 14642.
Antimicrobial Agents and Chemotherapy
|May 11, 1991
Summary
Trospectomycin showed good tolerance in men with chlamydial urethritis. However, this antibiotic failed to eradicate the infection, indicating it is not an effective treatment for Chlamydia trachomatis.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Chlamydia trachomatis is a common cause of urethritis.
- Aminocyclitol antibiotics are being investigated for antimicrobial properties.
Purpose of the Study:
- To evaluate the efficacy of trospectomycin in treating chlamydial urethritis.
Main Methods:
- Ten men with symptomatic, culture-positive chlamydial urethritis received a single 1-g intramuscular dose of trospectomycin.
- Post-treatment cultures were obtained approximately one week later to assess infection eradication.
Main Results:
- Trospectomycin was well tolerated by all participants.
- Chlamydial infection was not eradicated in any of the treated men, as confirmed by follow-up cultures.
Conclusions:
- Despite promising in vitro activity, a single intramuscular dose of trospectomycin was ineffective in eradicating Chlamydia trachomatis in vivo.
- Further investigation into alternative dosing regimens or different therapeutic applications of trospectomycin may be warranted.